Nivolumab in Preventing Colon Adenomas in Participants With Lynch Syndrome and a History of Partial Colectomy

Summary

This phase II trial studies how well nivolumab works in preventing colon adenomas in participants with Lynch syndrome and a history of surgery to remove part of the colon. Monoclonal antibodies, such as nivolumab, may interfere with the ability of tumor cells to grow and spread.

Timeline

Start

2018-10-04

Primary completion

2021-01-25

Completion

2021-01-25

Outcome

Outcome not reported

Stopped (Business): “Sponsor decision”

Drugs

Indications